Robert Landry
Director of Finance/CFO bei CHECKMATE PHARMACEUTICALS, INC.
Vermögen: 23 Mio $ am 31.03.2024
Profil
Robert E. Landry ist Chief Financial Officer & Executive VP-Finance bei Regeneron Pharmaceuticals, Inc. Zuvor war er Treasurer & Senior Vice President bei Pfizer Inc. Direktor Pharmazeutisches Marketing & Vertrieb bei Wyeth Australia Pty Ltd. Chief Financial Officer von Wyeth New Zealand und Treasurer & Principal Corporate Officer bei Wyeth Corp. (die alle Tochtergesellschaften von Pfizer Inc. sind). Herr Landry erwarb einen Bachelor-Abschluss an der University of Notre Dame.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.02.2024 | 23 963 ( 0,02% ) | 23 Mio $ | 31.03.2024 |
Aktive Positionen von Robert Landry
| Unternehmen | Position | Beginn |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director of Finance/CFO | 31.05.2022 |
| DECIBEL THERAPEUTICS, INC. | Director of Finance/CFO | 22.09.2023 |
Ehemalige bekannte Positionen von Robert Landry
| Unternehmen | Position | Ende |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director of Finance/CFO | 05.02.2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01.10.2012 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Treasurer | 01.10.2009 |
| Wyeth Australia Pty Ltd. | Director of Finance/CFO | 01.01.2006 |
| Wyeth New Zealand | Director of Finance/CFO | 01.01.2006 |
Ausbildung von Robert Landry
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| Wyeth Australia Pty Ltd. | |
| Wyeth New Zealand | |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
